Paper7224366
Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.
Bowden TA and 2 others. Am Surg, 1981. Cited by 141 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Papers, record 7224366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7224366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enema | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Feces | Major topic |
| Female | |
| Homeostasis | |
| Humans | |
| Intestines | |
| Intubation, Gastrointestinal | |
| Male | |
| Middle Aged |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,924,474 | Jinzhi and fecal microbiota transplantation: a comparative review of historical and modern microbial therapeutics. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41924474 | PubMed |
| 41,530,607 | Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back. | Curr Gastroenterol Rep | 2026 | https://conductscience.org/library/papers/41530607 | PubMed |
| 40,806,882 | Intestinal Microbiota and Fecal Transplantation in Patients with Inflammatory Bowel Disease and Clostridioides difficile: An Updated Literature Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40806882 | PubMed |
| 37,189,634 | Fecal Microbiota Transplantation in Inflammatory Bowel Disease. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189634 | PubMed |
| 36,949,306 | Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/36949306 | PubMed |
| 36,654,766 | Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends. | Can J Infect Dis Med Microbiol | 2023 | https://conductscience.org/library/papers/36654766 | PubMed |
| 36,558,874 | The History of the Intestinal Microbiota and the Gut-Brain Axis. | Pathogens | 2022 | https://conductscience.org/library/papers/36558874 | PubMed |
| 36,357,745 | Fecal microbiota transplantation as a promising treatment option for osteoporosis. | J Bone Miner Metab | 2022 | https://conductscience.org/library/papers/36357745 | PubMed |
| 30,890,952 | Effects of Early Intervention With Maternal Fecal Bacteria and Antibiotics on Liver Metabolome and Transcription in Neonatal Pigs. | Front Physiol | 2019 | https://conductscience.org/library/papers/30890952 | PubMed |
| 30,598,589 | Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. | Ann Gastroenterol | 2019 | https://conductscience.org/library/papers/30598589 | PubMed |
| 30,156,993 | Modulation of the immune system by the gut microbiota in the development of type 1 diabetes. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/30156993 | PubMed |
| 29,479,439 | Treatment of recurrent Clostridium difficile colitis: a narrative review. | Gastroenterol Rep (Oxf) | 2018 | https://conductscience.org/library/papers/29479439 | PubMed |
| 29,123,385 | Clostridium difficile infection in the elderly: an update on management. | Clin Interv Aging | 2017 | https://conductscience.org/library/papers/29123385 | PubMed |
| 28,609,252 | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | Gut Microbes | 2017 | https://conductscience.org/library/papers/28609252 | PubMed |
| 28,491,142 | Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation. | Ther Adv Gastroenterol | 2017 | https://conductscience.org/library/papers/28491142 | PubMed |
| 28,286,449 | Treatment of Recurrent Clostridium difficile Diarrhea. | Gastroenterol Hepatol (N Y) | 2006 | https://conductscience.org/library/papers/28286449 | PubMed |
| 28,257,555 | Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28257555 | PubMed |
| 27,516,814 | Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment. | Ont Health Technol Assess Ser | 2016 | https://conductscience.org/library/papers/27516814 | PubMed |
| 27,489,376 | Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. | Clin Psychopharmacol Neurosci | 2016 | https://conductscience.org/library/papers/27489376 | PubMed |
| 27,104,515 | Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27104515 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7224366
GET https://conductscience.org/api/papers/v1/7224366/cited_by?page=2